Brief: Scribe Therapeutics - IPO Price Expected Between $13 And $15 Per Share - SEC Filing
BRIEF-Scribe Therapeutics - IPO Price Expected Between $13 And $15 Per Share - SEC Filing July 20 (Reuters) - Scribe Therapeutics Inc SCTX.O:
SCRIBE THERAPEUTICS - IPO PRICE EXPECTED BETWEEN $13 AND $15 PER SHARE - SEC FILING
SCRIBE THERAPEUTICS - LAUNCHES IPO OF 7,150,000 COMMON SHARES - SEC FILING
SCRIBE THERAPEUTICS - AVENTIS AND GENZYME TO PURCHASE $7.50 MILLION IN SHARES VIA CONCURRENT PRIVATE PLACEMENT - SEC FILING
SCRIBE THERAPEUTICS INC - ELI LILLY HAS INDICATED INTEREST IN PURCHASING CO'S SHARES OF COMMON STOCK AT IPO PRICE
Source text: [ID:n0001193125-26-308330]
Further company coverage: SCTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sanofi SA
See all newsEdenTree fund manager Hiorns has bought up French stocks despite civil unrest (updated)
Early US flu season, current strain may signal risk for younger people; doctors urge shots
Brief: Sanofi Starts Work On Insulin Facility In Germany
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Europe Research Roundup: AJ Bell, CMC Markets, Nestle